IL-13RA2 Rekombinanter Antikörper
IL-13RA2 Rekombinant Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
242742F11
Kat-Nr. : 85631-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
85631-1-PBS bindet in WB, Indirect ELISA IL-13RA2 und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | IL-13RA2 fusion protein Eg3118 |
| Vollständiger Name | interleukin 13 receptor, alpha 2 |
| Berechnetes Molekulargewicht | 44 kDa |
| Beobachtetes Molekulargewicht | 65 kDa |
| GenBank-Zugangsnummer | NM_008356.4 |
| Gene symbol | Il13ra2 |
| Gene ID (NCBI) | 16165 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
IL13RA2, also named as IL13R and CD213a2, belongs to the type I cytokine receptor family. It binds as a monomer with high affinity to interleukin-13 (IL13), but not to interleukin-4 (IL4). IL13RA2 lacks the cytoplasmic domain for signaling, indicating that it acts as a decoy receptor. IL13RA2 gene polymorphisms have been associated with systemic sclerosis (PMID: 16981293). Overexpression of IL13RA2 gene has been reported in several types of cancer, including melanoma, lung cancer, and brain tumor, which makes it a potential immunotherapeutic target (PMID: 19895199; 24970476; 24021875).

